Nippon Shinyaku Co., Ltd.

Everything filed on one company: the documents, the statements, the register, the board, the buyback and the property table — each figure as filed, with the report it came from.

Latest values as text and table

Nippon Shinyaku Co., Ltd.

Nippon Shinyaku Co., Ltd. (日本新薬株式会社, 4516), Pharmaceutical. 26 cross-shareholdings, a board of 16 and 10 largest shareholders, as filed on EDINET for the year to March 2026. EDINET filing S100YGRG, filed 2026-06-23. Source: company filings on EDINET (Financial Services Agency of Japan).

Financial summary

Five-year summary as filed, latest filing per fiscal year
Fiscal year endRevenue (¥bn)Profit (¥bn)Total assets (¥bn)EPS (¥)DPS (¥)Employees
2022-03-31137.525.0219.9370.97110.002,125
2023-03-31144.222.8237.5338.70114.002,186
2024-03-31148.325.9263.4383.82124.002,213
2025-03-31160.232.6283.6483.40124.002,243
2026-03-31170.829.7346.4441.00124.002,309

Source: company filings on EDINET (Financial Services Agency of Japan). · JSON

Cross-shareholdings

Ten largest cross-shareholdings by book value, latest annual report
Company heldSharesBook value (¥bn)% of shares outstanding
Capricor Therapeutics Inc.4,944,42924.0—
Mitsubishi UFJ Financial Group, Inc.3,324,9308.60.0
Kyoto Financial Group, Inc.1,599,2086.50.6
ONO　PHARMACEUTICAL　CO.,　LTD.941,0002.40.2
MEDIPAL HOLDINGS CORPORATION791,7102.30.4
Tokio Marine Holdings, Inc.267,3402.00.0
HORIBA, Ltd.100,0001.80.2
Mitsubishi Logistics Corporation1,185,0001.60.3
TOHO HOLDINGS CO.,LTD.325,4531.50.5
Shimadzu Corporation206,0000.80.1

% of shares outstanding: shares held ÷ (issuer's issued shares − treasury shares) × 100, both as filed, the denominator taken from the issuer's own annual securities report nearest the holding's fiscal year end

Source: company filings on EDINET (Financial Services Agency of Japan). · JSON · Markdown